Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Role of the embryonic protein SOX2 in cholangiocarcinoma.

Sun Q, Li J, Wang G, Xie Y.

Cell Biochem Biophys. 2014 Nov;70(2):1311-6. doi: 10.1007/s12013-014-0056-8.

PMID:
24906237
2.

Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma.

Gu MJ, Jang BI.

Pathol Oncol Res. 2014 Jul;20(3):655-60. doi: 10.1007/s12253-014-9745-2. Epub 2014 Jan 31.

PMID:
24482053
3.

MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.

Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S.

BMC Cancer. 2014 Dec 5;14:917. doi: 10.1186/1471-2407-14-917.

4.

Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.

Xiong GP, Zhang JX, Gu SP, Wu YB, Liu JF.

Neoplasma. 2012;59(4):409-15. doi: 10.4149/neo_2012_053.

PMID:
22489696
5.

Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.

Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, Nie W.

Int J Mol Med. 2014 Sep;34(3):661-8. doi: 10.3892/ijmm.2014.1823. Epub 2014 Jun 27.

6.

Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L.

Hepatology. 2014 Mar;59(3):935-46. doi: 10.1002/hep.26705. Epub 2014 Jan 29.

PMID:
24037855
7.

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C.

Mol Cancer. 2010 Jan 24;9:13. doi: 10.1186/1476-4598-9-13.

8.

Characterization of EGFR family gene aberrations in cholangiocarcinoma.

Yang X, Wang W, Wang C, Wang L, Yang M, Qi M, Su H, Sun X, Liu Z, Zhang J, Qin X, Han B.

Oncol Rep. 2014 Aug;32(2):700-8. doi: 10.3892/or.2014.3261. Epub 2014 Jun 13.

PMID:
24927194
9.

Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.

Pongcharoen P, Jinawath A, Tohtong R.

Clin Exp Metastasis. 2011 Dec;28(8):827-39. doi: 10.1007/s10585-011-9414-8. Epub 2011 Aug 11.

PMID:
21833756
10.

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.

Obchoei S, Weakley SM, Wongkham S, Wongkham C, Sawanyawisuth K, Yao Q, Chen C.

Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102.

11.

Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.

Zhang H, Li Z, Chu B, Zhang F, Zhang Y, Ke F, Chen Y, Xu Y, Liu S, Zhao S, Liang H, Weng M, Wu X, Li M, Wu W, Quan Z, Liu Y, Zhang Y, Gong W.

Tumour Biol. 2016 Jun;37(6):8305-15. doi: 10.1007/s13277-015-4704-4. Epub 2016 Jan 4.

PMID:
26729195
12.

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, Ning SL, Yang H, Suo N, Chen YX.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):54-60. doi: 10.1016/j.bbrc.2014.02.050. Epub 2014 Feb 22.

PMID:
24565842
13.

Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.

Lee GR, Jang SH, Kim CJ, Kim AR, Yoon DJ, Park NH, Han IS.

Clin Exp Metastasis. 2014 Dec;31(8):897-907. doi: 10.1007/s10585-014-9678-x. Epub 2014 Sep 14.

PMID:
25217963
14.

EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.

Clapéron A, Mergey M, Nguyen Ho-Bouldoires TH, Vignjevic D, Wendum D, Chrétien Y, Merabtene F, Frazao A, Paradis V, Housset C, Guedj N, Fouassier L.

J Hepatol. 2014 Aug;61(2):325-32. doi: 10.1016/j.jhep.2014.03.033. Epub 2014 Apr 3.

PMID:
24704591
15.

Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.

Liu R, Zhao R, Zhou X, Liang X, Campbell DJ, Zhang X, Zhang L, Shi R, Wang G, Pandak WM, Sirica AE, Hylemon PB, Zhou H.

Hepatology. 2014 Sep;60(3):908-18. doi: 10.1002/hep.27085. Epub 2014 Jul 28.

16.

SOX4 is associated with poor prognosis in cholangiocarcinoma.

Wang W, Zhang J, Zhan X, Lin T, Yang M, Hu J, Han B, Hu S.

Biochem Biophys Res Commun. 2014 Sep 26;452(3):614-21. doi: 10.1016/j.bbrc.2014.08.124. Epub 2014 Aug 30.

PMID:
25181339
17.

High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.

Jin J, Ryu HS, Lee KB, Jang JJ.

PLoS One. 2014 Feb 28;9(2):e90247. doi: 10.1371/journal.pone.0090247. eCollection 2014 Feb 28.

18.

Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.

Tan XY, Chang S, Liu W, Tang HH.

Gut Liver. 2014 Mar;8(2):196-204. doi: 10.5009/gnl.2014.8.2.196. Epub 2013 Nov 5.

19.

MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.

Li J, Tian F, Li D, Chen J, Jiang P, Zheng S, Li X, Wang S.

FEBS Lett. 2014 Sep 17;588(18):3491-500. doi: 10.1016/j.febslet.2014.08.008. Epub 2014 Aug 14.

20.

Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.

Yu Y, Liao M, Liu R, Chen J, Feng H, Fu Z.

World J Surg Oncol. 2014 Mar 31;12:78. doi: 10.1186/1477-7819-12-78.

Supplemental Content

Support Center